SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0    0 A 57-year-old male singer with noninsulin-dependent ( type 2 ) diabetes mellitus and primary hyperparathyroidism presented with a complaint of diplacusis in the right ear of 16 months ' duration .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0    0 A_ZZ1 57-year-old_JJ male_JJ_NN1 singer_NN1 with_IW noninsulin-dependent_JJ_NN1@ (_Y type_NN1 2_MC )_Y diabetes_NN1 mellitus_NN1 and_CC primary_JJ_NN1 hyperparathyroidism_NN1 presented_VVN_VVD with_IW a_AT1 complaint_NN1 of_IO diplacusis_NN1 in_II the_AT right_JJ_NN1 ear_NN1 of_IO 16_MC months_NNT2 '_GE duration_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0    1 The diplacusis was accompanied by tinnitus , aural fullness , and hyperacusis in the same ear : " The patient described the diplacusis as a harmonic of a fundamental sound in response to external sound and to his own voice .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0    1 The_AT diplacusis_NN1 was_VBDZ accompanied_VVN by_II tinnitus_NN1_JJ ,_Y aural_JJ fullness_NN1 ,_Y and_CC hyperacusis_NN1 in_II the_AT same_DA ear_NN1 :_Y "_Y The_AT patient_NN1 described_VVD_VVN the_AT diplacusis_NN1 as_II a_AT1 harmonic_NN1@_JJ of_IO a_AT1 fundamental_JJ sound_NN1 in_II31 response_II32 to_II33 external_JJ sound_NN1 and_CC to_II his_APPGE own_DA voice_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0    2 When the diplacusis was most severe , he would also hear a third sound , either in response to an external sound or as a spontaneous sound that was close to the quality of his tinnitus .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0    2 When_CS the_AT diplacusis_NN1 was_VBDZ most_RGT severe_JJ ,_Y he_PPHS1 would_VM also_RR hear_VVI a_AT1 third_MD sound_NN1 ,_Y either_RR in_II31 response_II32 to_II33 an_AT1 external_JJ sound_NN1 or_CC as_II_CSA a_AT1 spontaneous_JJ sound_NN1 that_CST_DD1 was_VBDZ close_JJ to_II the_AT quality_NN1 of_IO his_APPGE tinnitus_NN1_JJ ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0    3 " The tinnitus seemed to be triggered by the intake of dairy and salicylate products , and it could be controlled to some degree by avoidance of these substances .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0    3 "_Y The_AT tinnitus_NN1 seemed_VVD to_TO be_VBI triggered_VVN by_II the_AT intake_NN1 of_IO dairy_NN1 and_CC salicylate_VV0_NN1 products_NN2 ,_Y and_CC it_PPH1 could_VM be_VBI controlled_VVN to_II some_DD degree_NN1 by_II avoidance_NN1 of_IO these_DD2 substances_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0    4 Another type of " howling " tinnitus arose either spontaneously or in association with the intake of these products .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0    4 Another_DD1 type_NN1 of_IO "_Y howling_JJ_VVG "_Y tinnitus_NN1 arose_VVD either_RR spontaneously_RR or_CC in_II31 association_II32 with_II33 the_AT intake_NN1 of_IO these_DD2 products_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0    5 " The aural fullness was intermittent , although it appeared to be related to the intake of dairy products and salt .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0    5 "_Y The_AT aural_JJ fullness_NN1 was_VBDZ intermittent_JJ ,_Y although_CS it_PPH1 appeared_VVD to_TO be_VBI related_VVN to_II the_AT intake_NN1 of_IO dairy_NN1 products_NN2 and_CC salt_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0    6 " The hyperacusis Four months after the onset of these symptoms , the patient had experienced a 1-week period of recurrent mild positional rotary vertigo .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0    6 "_Y The_AT hyperacusis_NN1 Four_MC months_NNT2 after_II_CS the_AT onset_NN1 of_IO these_DD2 symptoms_NN2 ,_Y the_AT patient_NN1 had_VHD experienced_VVN a_AT1 1-week_JJ_NNT1 period_NN1 of_IO recurrent_JJ mild_JJ positional_JJ rotary_JJ_NN1 vertigo_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0    7 Each episode lasted for approximately 90 seconds .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0    7 Each_DD1 episode_NN1 lasted_VVD_VVN@ for_IF approximately_RR 90_MC seconds_NNT2 ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0    8 His family history included a sister who had undergone stapedectomy .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0    8 His_APPGE family_NN1 history_NN1 included_VVD_VVN a_AT1 sister_NN1 who_PNQS had_VHD undergone_VVN stapedectomy_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0    9 He was taking metformin for the diabetes .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0    9 He_PPHS1 was_VBDZ taking_VVG metformin_NN1 for_IF the_AT diabetes_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   10 The patient said that the diplacusis was very distracting during his daily activities , although he had been able to overcome the response from his own voice by altering his vocal technique .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   10 The_AT patient_NN1 said_VVD that_CST the_AT diplacusis_NN1 was_VBDZ very_RG distracting_JJ@_VVG during_II his_APPGE daily_JJ activities_NN2 ,_Y although_CS he_PPHS1 had_VHD been_VBN able_JK to_TO overcome_VVI the_AT response_NN1 from_II his_APPGE own_DA voice_NN1 by_II altering_VVG his_APPGE vocal_JJ technique_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   11 He had been previously treated with three intratympanic corticosteroids , but he felt that this treatment might have only made his symptoms worse .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   11 He_PPHS1 had_VHD been_VBN previously_RR treated_VVN with_IW three_MC intratympanic_JJ corticosteroids_NN2 ,_Y but_CCB he_PPHS1 felt_VVD that_CST this_DD1 treatment_NN1 might_VM have_VHI only_RR made_VVN his_APPGE symptoms_NN2 worse_JJR_RRR@ ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   12 He had also been treated with oral prednisone , betahistine , diuretics , and liothyronine without benefit .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   12 He_PPHS1 had_VHD also_RR been_VBN treated_VVN with_IW oral_JJ prednisone_NN1 ,_Y betahistine_NN1_JJ ,_Y diuretics_NN2_NN1 ,_Y and_CC liothyronine_NN1_JJ without_IW benefit_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   13 The patient had brought with him the results of serial audiometric tests that had showed a fluctuating low-frequency hearing loss in the right ear , although one of these tests showed that the right ear was normal .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   13 The_AT patient_NN1 had_VHD brought_VVN with_IW him_PPHO1 the_AT results_NN2 of_IO serial_JJ audiometric_JJ tests_NN2 that_CST had_VHD showed_VVN a_AT1 fluctuating_JJ low-frequency_JJ hearing_NN1 loss_NN1 in_II the_AT right_JJ_NN1 ear_NN1 ,_Y although_CS one_MC1 of_IO these_DD2 tests_NN2 showed_VVD that_CST the_AT right_JJ_NN1 ear_NN1 was_VBDZ normal_JJ ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   14 He himself had not noticed any hearing loss .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   14 He_PPHS1 himself_PPX1 had_VHD not_XX noticed_VVN any_DD hearing_NN1 loss_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   15 Findings on previous magnetic resonance imaging with enhancement had been negative for any abnormality , and level .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   15 Findings_NN2 on_II previous_JJ magnetic_JJ resonance_NN1 imaging_VVG_NN1 with_IW enhancement_NN1 had_VHD been_VBN negative_JJ for_IF any_DD abnormality_NN1 ,_Y and_CC level_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   16 At the patient ' s first visit to the author ' s office , neurotologic testing with tuning forks revealed diplacusis at 512 , 2 , 048 , and 4 , 096 Hz .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   16 At_II the_AT patient_NN1 '_GE s_ZZ1 first_MD visit_NN1_VV0 to_II the_AT author_NN1 '_GE s_ZZ1 office_NN1 ,_Y neurotologic_JJ testing_NN1 with_IW tuning_VVG forks_NN2 revealed_VVD_VVN diplacusis_NN1 at_II 512_MC ,_Y 2_MC ,_Y 048_MC ,_Y and_CC 4_MC ,_Y 096_MC Hz_NNU ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   17 The patient said the sound from the 512- and 2 , 048-Hz tuning forks was louder in the right ear than in the left .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   17 The_AT patient_NN1 said_VVD the_AT sound_NN1 from_II the_AT 512-_NN1_JJ and_CC 2_MC ,_Y 048-Hz_JJ_NNU tuning_NN1@_VVG forks_NN2 was_VBDZ louder_JJR in_II the_AT right_JJ_NN1 ear_NN1 than_CSN in_II the_AT left_JJ_NN1@ ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   18 He experienced significantly more difficulty performing the sharpened tandem Romberg test with the right foot forward than with the left foot forward .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   18 He_PPHS1 experienced_VVD significantly_RR more_DAR difficulty_NN1 performing_VVG the_AT sharpened_JJ tandem_NN1 Romberg_NP1 test_NN1_VV0 with_IW the_AT right_JJ_NN1 foot_NN1 forward_RL than_CSN with_IW the_AT left_JJ foot_NN1 forward_RL ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   19 At the second visit , audiometry showed pure tones at 45 dB at 250 and 500 Hz , with both ears equal from 1. 0 kHz and higher .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   19 At_II the_AT second_MD visit_NN1 ,_Y audiometry_NN1 showed_VVD pure_JJ tones_NN2 at_II 45_MC dB_NNU at_II 250_MC and_CC 500_MC Hz_NNU ,_Y with_IW both_DB2 ears_NN2 equal_JJ_VV0% from_II 1._MC 0_MC kHz_NNU and_CC higher_JJR_RRR@ ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   20 High-frequency hearing testing revealed hearing in both ears to 15 kHz .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   20 High-frequency_JJ_NN1 hearing_NN1 testing_NN1_VVG revealed_VVD_VVN_JJ@ hearing_VVG_NN1 in_II both_DB2 ears_NN2 to_II 15_MC kHz_NNU ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   21 The tinnitus in the right ear could not be matched .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   21 The_AT tinnitus_NN1_JJ in_II the_AT right_JJ_NN1 ear_NN1 could_VM not_XX be_VBI matched_VVN ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   22 The speech-reception threshold was 20 dB in the right ear and 10 dB in the left .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   22 The_AT speech-reception_JJ_NN1 threshold_NN1 was_VBDZ 20_MC dB_NNU in_II the_AT right_JJ_NN1 ear_NN1 and_CC 10_MC dB_NNU in_II the_AT left_JJ_NN1@ ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   23 Speech discrimination in quiet and in simulated background noise was normal in both ears , although it was slightly less in the right .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   23 Speech_NN1 discrimination_NN1 in_II quiet_JJ_NN1@ and_CC in_II simulated_JJ background_NN1 noise_NN1 was_VBDZ normal_JJ in_II both_DB2 ears_NN2 ,_Y although_CS it_PPH1 was_VBDZ slightly_RR less_RRR_DAR in_II the_AT right_NN1_JJ ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   24 Otoacoustic emissions , both transient evoked and distortion product , were present Thin-section direct axial computed tomography ( CT ) of the right temporal bone revealed a large sclerotic plaque from the base at the footplate level to the apex , a moderate to large sclerotic plaque of the anterior oval window , and a moderately thickened spongiotic footplate , which the radiologist interpreted as otosclerosis of the right ear .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   24 Otoacoustic_JJ emissions_NN2 ,_Y both_RR_DB2 transient_JJ evoked_VVN_VVD and_CC distortion_NN1 product_NN1 ,_Y were_VBDR present_JJ_NN1 Thin-section_JJ_NN1 direct_JJ axial_JJ computed_JJ@ tomography_NN1 (_Y CT_NP1@_NN1 )_Y of_IO the_AT right_JJ_NN1 temporal_JJ bone_NN1 revealed_VVD_VVN a_AT1 large_JJ sclerotic_JJ plaque_NN1 from_II the_AT base_NN1 at_II the_AT footplate_NN1 level_NN1 to_II the_AT apex_NN1 ,_Y a_AT1 moderate_JJ to_II large_JJ sclerotic_JJ plaque_NN1 of_IO the_AT anterior_JJ oval_JJ_NN1 window_NN1 ,_Y and_CC a_AT1 moderately_RR thickened_VVN_VVD spongiotic_JJ footplate_NN1 ,_Y which_DDQ the_AT radiologist_NN1 interpreted_VVN_VVD as_CSA_II@ otosclerosis_NN1 of_IO the_AT right_JJ_NN1 ear_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   25 On the left side , CT revealed a small sclerotic plaque at the base of the temporal bone at the footplate level and some spotty demineralization posterior to the apex .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   25 On_II the_AT left_JJ side_NN1 ,_Y CT_NP1@_NN1 revealed_VVD a_AT1 small_JJ sclerotic_JJ plaque_NN1 at_II the_AT base_NN1 of_IO the_AT temporal_JJ bone_NN1 at_II the_AT footplate_NN1 level_NN1 and_CC some_DD spotty_JJ demineralization_NN1 posterior_NN1 to_II the_AT apex_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   26 A 2-hour glucose tolerance test showed diabetic levels of blood glucose and slightly elevated levels of insulin .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   26 A_AT1_ZZ1 2-hour_JJ glucose_NN1 tolerance_NN1 test_NN1 showed_VVD diabetic_JJ levels_NN2 of_IO blood_NN1 glucose_NN1 and_CC slightly_RR elevated_JJ_VVN levels_NN2 of_IO insulin_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   27 Thus , the patient was placed on a strict diabetic diet , and the metformin was continued .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   27 Thus_RR ,_Y the_AT patient_NN1 was_VBDZ placed_VVN on_II a_AT1 strict_JJ diabetic_JJ_NN1 diet_NN1 ,_Y and_CC the_AT metformin_NN1 was_VBDZ continued_VVN ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   28 He was also started on risedronate 30 mg twice weekly along with calcium , vitamin D , and sodium monofluorophosphate to address the otosclerosis .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   28 He_PPHS1 was_VBDZ also_RR started_VVN on_II risedronate_NN1_JJ 30_MC mg_NNU twice_RR weekly_JJ_RR@ along_II21 with_II22 calcium_NN1 ,_Y vitamin_NN1 D_ZZ1 ,_Y and_CC sodium_NN1 monofluorophosphate_NN1 to_TO address_VVI the_AT otosclerosis_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   29 At follow-up 3 months later , the patient reported that the diplacusis had become a little worse , the aural fullness more pervasive , and the hyperacusis worse on the days he took the risedronate .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   29 At_II follow-up_NN1_JJ 3_MC months_NNT2 later_RRR ,_Y the_AT patient_NN1 reported_VVD_VVN that_CST the_AT diplacusis_NN1 had_VHD become_VVN@ a_RR21 little_RR22 worse_JJR_RRR@ ,_Y the_AT aural_JJ fullness_NN1 more_RGR pervasive_JJ ,_Y and_CC the_AT hyperacusis_NN1 worse_RRR@_JJR on_II the_AT days_NNT2 he_PPHS1 took_VVD the_AT risedronate_NN1_JJ ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   30 Repeat audiometry placed on an alternating regimen of etidronate 400 mg/day for 2 weeks and risedronate 30 mg twice weekly for 4 weeks .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   30 Repeat_VV0 audiometry_NN1 placed_VVN on_II an_AT1 alternating_JJ regimen_NN1 of_IO etidronate_NN1_JJ 400_MC mg/day_FU for_IF 2_MC weeks_NNT2 and_CC risedronate_VV0_NN1_JJ 30_MC mg_NNU twice_RR weekly_JJ for_IF 4_MC weeks_NNT2 ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   31 The patient returned in another 3 months and reported that the diplacusis was better toward the end of the etidronate cycle but worse on days when he took risedronate .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   31 The_AT patient_NN1 returned_VVN_VVD in_II another_DD1 3_MC months_NNT2 and_CC reported_VVN that_CST the_AT diplacusis_NN1 was_VBDZ better_JJR toward_II the_AT end_NN1 of_IO the_AT etidronate_JJ_NN1 cycle_NN1 but_CCB worse_RRR@_JJR on_II days_NNT2 when_RRQ he_PPHS1 took_VVD risedronate_NN1_JJ ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   32 The diplacusis had become better in that fewer pitches were affected .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   32 The_AT diplacusis_NN1 had_VHD become_VVN@ better_RRR in_II that_DD1 fewer_DAR pitches_NN2 were_VBDR affected_VVN ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   33 Overall , the tinnitus and the aural fullness were better than they had been at the previous visit , although he did feel pressure in the right ear when he did not follow his diet .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   33 Overall_RR_NN1 ,_Y the_AT tinnitus_NN1_JJ and_CC the_AT aural_JJ fullness_NN1 were_VBDR better_RRR_JJR than_CSN they_PPHS2 had_VHD been_VBN at_II the_AT previous_JJ visit_NN1 ,_Y although_CS he_PPHS1 did_VDD feel_VVI pressure_NN1 in_II the_AT right_JJ_NN1 ear_NN1 when_CS_RRQ he_PPHS1 did_VDD not_XX follow_VVI his_APPGE diet_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   34 The hyperacusis was unchanged , and the results of hearing tests were unchanged .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   34 The_AT hyperacusis_NN1 was_VBDZ unchanged_JJ ,_Y and_CC the_AT results_NN2 of_IO hearing_VVG_NN1 tests_NN2 were_VBDR unchanged_JJ ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   35 The alternating bisphosphonate regimen was changed to etidronate 400 mg/day for 2 weeks and risedronate 30 mg twice weekly for 6 weeks .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   35 The_AT alternating_JJ bisphosphonate_JJ_NN1 regimen_NN1 was_VBDZ changed_VVN to_TO etidronate_VVI 400_MC mg/day_FU for_IF 2_MC weeks_NNT2 and_CC risedronate_VV0_NN1_JJ 30_MC mg_NNU twice_RR weekly_JJ for_IF 6_MC weeks_NNT2 ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   36 Four months later , no change had occurred in the diplacusis ; it remained better toward the end of the etidronate cycle and worse during the days on risedronate .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   36 Four_MC months_NNT2 later_RRR ,_Y no_AT change_NN1 had_VHD occurred_VVN in_II the_AT diplacusis_NN1 ;_Y it_PPH1 remained_VVD better_RRR_JJR toward_II the_AT end_NN1 of_IO the_AT etidronate_JJ_NN1 cycle_NN1 and_CC worse_JJR_RRR@ during_II the_AT days_NNT2 on_II risedronate_NN1_JJ ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   37 On a comparative listening test with a dial tone , there was less distortion in the right ear .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   37 On_II a_AT1 comparative_JJ listening_JJ_NN1 test_NN1 with_IW a_AT1 dial_NN1 tone_NN1 ,_Y there_EX was_VBDZ less_DAR_RRR distortion_NN1 in_II the_AT right_JJ_NN1 ear_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   38 The tinnitus remained remained present , but the patient was able to ignore it .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   38 The_AT tinnitus_NN1 remained_VVD_VVN remained_VVD_VVN present_NN1_JJ ,_Y but_CCB the_AT patient_NN1 was_VBDZ able_JK to_TO ignore_VVI it_PPH1 ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   39 The hyperacusis was less frequent and less acute .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   39 The_AT hyperacusis_NN1 was_VBDZ less_RGR frequent_JJ and_CC less_RGR acute_JJ ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   40 There were no significant changes in the results of hearing tests .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   40 There_EX were_VBDR no_AT significant_JJ changes_NN2 in_II the_AT results_NN2 of_IO hearing_VVG_NN1 tests_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   41 The patient offered that he found the diabetes diet to be " draconian .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   41 The_AT patient_NN1 offered_VVD_VVN that_CST he_PPHS1 found_VVD the_AT diabetes_NN1 diet_NN1 to_TO be_VBI "_Y draconian_JJ ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   42 " The alternating bisphosphonate regimen was changed to etidronate 400 mg/day for 2 weeks and risedronate 30 mg twice weekly for 11 weeks .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   42 "_Y The_AT alternating_JJ bisphosphonate_JJ_NN1 regimen_NN1 was_VBDZ changed_VVN to_TO etidronate_VVI 400_MC mg/day_FU for_IF 2_MC weeks_NNT2 and_CC risedronate_VV0_NN1_JJ 30_MC mg_NNU twice_RR weekly_JJ for_IF 11_MC weeks_NNT2 ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   43 Six months later , which marked the 16th month of treatment overall , the patient returned ( and brought with him an article on monaural diplacusis ( n1 ) ) .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   43 Six_MC months_NNT2 later_RRR ,_Y which_DDQ marked_VVD@ the_AT 16th_MD month_NNT1 of_IO treatment_NN1 overall_NN1_RR ,_Y the_AT patient_NN1 returned_VVN_VVD (_Y and_CC brought_VVN_VVD with_IW him_PPHO1 an_AT1 article_NN1 on_II monaural_JJ_NN1 diplacusis_NN1 (_Y n1_FO )_Y )_Y ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   44 Since his previous visit , the diplacusis was much improved ; in fact , it had almost disappeared and was no longer a distraction .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   44 Since_CS his_APPGE previous_JJ visit_NN1 ,_Y the_AT diplacusis_NN1 was_VBDZ much_RR improved_VVN_JJ_VVD ;_Y in_II fact_NN1 ,_Y it_PPH1 had_VHD almost_RR disappeared_VVN and_CC was_VBDZ no_RR21 longer_RR22 a_AT1 distraction_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   45 The tinnitus and aural fullness were the same as they had been at the previous visit , but the hyperacusis was almost gone .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   45 The_AT tinnitus_NN1_JJ and_CC aural_JJ fullness_NN1 were_VBDR the_AT same_DA as_CSA they_PPHS2 had_VHD been_VBN at_II the_AT previous_JJ visit_NN1 ,_Y but_CCB the_AT hyperacusis_NN1 was_VBDZ almost_RR gone_VVN ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   46 The results of repeat hearing tests remained the same with the exception of improved findings with respect to the transient evoked otoacoustic emissions ( figure ) .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   46 The_AT results_NN2 of_IO repeat_VV0_NN1% hearing_VVG_NN1 tests_NN2 remained_VVD the_AT same_DA with_IW the_AT exception_NN1 of_IO improved_JJ findings_NN2 with_II31 respect_II32 to_II33 the_AT transient_JJ evoked_VVD_VVN otoacoustic_JJ emissions_NN2 (_Y figure_NN1 )_Y ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   47 Compared with the previous visit , the patient ' s hearing was Hz .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   47 Compared_VVN with_IW the_AT previous_JJ visit_NN1 ,_Y the_AT patient_NN1 '_GE s_ZZ1 hearing_NN1 was_VBDZ Hz_NNU ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   48 This is a case of monaural diplacusis. n2 Based on the patient ' s response to treatment , the etiology appears to be otosclerosis and type 2 diabetes with elevated insulin levels .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   48 This_DD1 is_VBZ a_AT1 case_NN1 of_IO monaural_JJ_NN1 diplacusis._NNU n2_FO Based_VVN on_II the_AT patient_NN1 '_GE s_ZZ1 response_NN1 to_II treatment_NN1 ,_Y the_AT etiology_NN1 appears_VVZ to_TO be_VBI otosclerosis_NN1 and_CC type_NN1 2_MC diabetes_NN1 with_IW elevated_JJ insulin_NN1 levels_NN2 ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   49 The intratympanic corticosteroids might have produced a permanent hearing loss as a result of their effect on osteoprotegerin in the inner ear. ( n3 , n4 ) Figure .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   49 The_AT intratympanic_JJ corticosteroids_NN2 might_VM have_VHI produced_VVN a_AT1 permanent_JJ hearing_NN1 loss_NN1 as_II a_AT1 result_NN1 of_IO their_APPGE effect_NN1 on_II osteoprotegerin_NN1 in_II the_AT inner_JJ ear._NNU (_Y n3_FO ,_Y n4_FO )_Y Figure_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   50 Graphs show the transient evoked otoacoustic emissions before treatment ( A ) and after 16 months of treatment ( B ) .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   50 Graphs_NN2 show_VV0 the_AT transient_JJ evoked_VVD_VVN otoacoustic_JJ emissions_NN2 before_II_CS treatment_NN1 (_Y A_ZZ1 )_Y and_CC after_II_CS 16_MC months_NNT2 of_IO treatment_NN1 (_Y B_ZZ1 )_Y ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   51 L : References ( n1 .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   51 L_ZZ1_NP1@ :_Y References_NN2 (_Y n1_FO ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   52 ) Ward W. Tonal monaural diplacusis .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   52 )_Y Ward_NP1 W._NP1 Tonal_JJ monaural_JJ_NN1 diplacusis_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   53 J Acoust Soc Am 1955 ; 27 : 365-72. ( n2 .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   53 J_NP1@_ZZ1 Acoust_NP1 Soc_NP1 Am_RA@ 1955_MC ;_Y 27_MC :_Y 365-72._MCMC (_Y n2_FO ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   54 ) Knight RD .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   54 )_Y Knight_NP1 RD_NNL1 ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   55 Diplacusis , hearing threshold and otoacoustic emissions in an episode of sudden , unilateral cochlear hearing loss .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   55 Diplacusis_NN1_NP1@ ,_Y hearing_VVG_NN1 threshold_NN1 and_CC otoacoustic_JJ emissions_NN2 in_II an_AT1 episode_NN1 of_IO sudden_JJ ,_Y unilateral_JJ cochlear_JJ hearing_NN1 loss_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   56 Int J Audiol 2004 ; 43(1) : 45-53. ( n3 .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   56 Int_ZZ_J J_ZZ1_NP1@ Audiol_NP1_VV0_NN1 2004_MC ;_Y 43(1)_FO :_Y 45-53._MCMC (_Y n3_FO ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   57 ) Zehnder AF , Kristiansen AG , Adams JC , et al .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   57 )_Y Zehnder_NP1 AF_NP1 ,_Y Kristiansen_NP1 AG_FO ,_Y Adams_NP1 JC_NP1 ,_Y et_RA21 al_RA22 ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   58 Osteoprotegerin in the inner ear may inhibit bone remodeling in the otic capsule .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   58 Osteoprotegerin_NN1_NP1@ in_II the_AT inner_JJ ear_NN1 may_VM inhibit_VVI bone_NN1 remodeling_VVG in_II the_AT otic_JJ capsule_NN1 ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   59 Laryngoscope 2005 ; 115(1) : 172-7. ( n4 .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   59 Laryngoscope_NN1_NP1@ 2005_MC ;_Y 115(1)_FO :_Y 172-7._MCMC (_Y n4_FO ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   60 ) Brookler K. Basis for understanding : 160-1 .
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   60 )_Y Brookler_NP1@ K._NP1 Basis_NN1 for_IF understanding_VVG :_Y 160-1_MCMC ._Y
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  A    0   61 By Kenneth H. Brookler , MD , MS , FRCSC , From Neurotologic Associates , PC , New York City.
SENTPOS COCA_acad_wlp_2009_04_FILE##4071313 COCA  B    0   61 By_II Kenneth_NP1 H._NP1 Brookler_NP1 ,_Y MD_NNA ,_Y MS_NN1 ,_Y FRCSC_NP1 ,_Y From_II Neurotologic_JJ Associates_NN2 ,_Y PC_NN1 ,_Y New_NP1 York_NP1 City._NP1
